Canada's Ebola vaccine timeline


  • Vaccine developed at the Agency's National Microbiology Laboratory
  • Patent protection


  • Experiments done on animals to test effectiveness


  • Commercial license granted to NewLink Genetics


  • One lot, approximately 1500 vials, of Ebola vaccine manufactured for research and clinical trials


  • Canada donates vials of vaccine to the WHO
  • Clinical trials begin in healthy people to test for safety
  • 800 vials of the vaccine shipped to the WHO


  • Clinical trials on hundreds of healthy people to test for efficacy
  • Manufacturing vials of vaccine for trials

And beyond

  • Drug regulators like Health Canada will receive application to approve the vaccine
  • Health Canada to review research data and approve if it deems it safe and effective
  • Mass manufacturing begins

Download the alternative format
(PDF format, 241 KB, 1 page)

Date published: 2015

Page details

Date modified: